Spontaneous Versus Secondary Thrombosis in Congenital Heterozygous Plasminogen Deficiency – Rebuttal

Please copy the URL and add it into your RSS Feed Reader.

Thromb Haemost 1993; 69(05): 531
DOI: 10.1055/s-0038-1651652

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

T Shigekiyo

The First Department of Internal Medicine, School of Medicine, The University of Tokushima, Tokushima, Japan

Received 01 February 1993

Accepted after revision 01 February 1993

Publication Date:
25 July 2018 (online)

References
1 Shigekiyo T, Uno Y, Tomonari A, Satoh K, Hondo H, Ueda S, Saito S. Type I congenital plasminogen deficiency is not a risk factor for thrombosis. Thromb Haemostas 1992; 67: 189-192

Reference Link Ris
PubMed Search in Google Scholar
2 Mannucci PM, Kluft C, Traas DW, Seveso P, D’Angelo A. Congenital plasminogen deficiency associated with venous thromboembolism: therapeutic trial with stanozolol. Br J Haematol 1986; 63: 753-759

Reference Link Ris
Crossref PubMed Search in Google Scholar
3 Dolan G, Greaves M, Cooper P, Preston FE. Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. Br J Haematol 1988; 70: 417-421

Reference Link Ris
Crossref PubMed Search in Google Scholar
4 Shigekiyo T, Tomonari A, Uno Y, Kishi Y. Danazol therapy in hypoplasminogenemia. Thromb Haemostas 1992; 68: 233-234

Reference Link Ris
PubMed Search in Google Scholar